These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12952843)

  • 1. Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina.
    Hirai N; Kawano H; Yasue H; Shimomura H; Miyamoto S; Soejima H; Kajiwara I; Sakamoto T; Yoshimura M; Nakamura H; Yodoi J; Ogawa H
    Circulation; 2003 Sep; 108(12):1446-50. PubMed ID: 12952843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-receptor antagonist losartan does not prevent nitroglycerin tolerance in patients with coronary artery disease.
    Longobardi G; Ferrara N; Leosco D; Abete P; Furgi G; Cacciatore F; Corbi G; Pescatore R; Rengo F
    Cardiovasc Drugs Ther; 2004 Sep; 18(5):363-70. PubMed ID: 15717138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. East Asians Variant Mitochondrial Aldehyde Dehydrogenase 2 Genotype Exacerbates Nitrate Tolerance in Patients With Coronary Spastic Angina.
    Mizuno Y; Harada E; Kugimiya F; Shono M; Kusumegi I; Yoshimura M; Kinoshita K; Yasue H
    Circ J; 2020 Feb; 84(3):479-486. PubMed ID: 32009064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
    Savonitto S; Motolese M; Agabiti-Rosei E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.
    Abrams J
    Drugs; 1987 Sep; 34(3):391-403. PubMed ID: 3119308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy.
    Parker JO; Parker JD; Caldwell RW; Farrell B; Kaesemeyer WH
    J Am Coll Cardiol; 2002 Apr; 39(7):1199-203. PubMed ID: 11923046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrate therapy for angina pectoris. Current concepts about mechanism of action and evaluation of currently available preparations.
    Corwin S; Reiffel JA
    Arch Intern Med; 1985 Mar; 145(3):538-43. PubMed ID: 3919668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
    Knorr M; Hausding M; Kröller-Schuhmacher S; Steven S; Oelze M; Heeren T; Scholz A; Gori T; Wenzel P; Schulz E; Daiber A; Münzel T
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2223-31. PubMed ID: 21757654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
    Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
    G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association.
    Takahashi J; Nihei T; Takagi Y; Miyata S; Odaka Y; Tsunoda R; Seki A; Sumiyoshi T; Matsui M; Goto T; Tanabe Y; Sueda S; Momomura S; Yasuda S; Ogawa H; Shimokawa H;
    Eur Heart J; 2015 Jan; 36(4):228-37. PubMed ID: 25189599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiotensin II-receptor antagonist losartan does not prevent hemodynamic or vascular tolerance to nitroglycerin.
    Milone SD; Azevedo ER; Forster C; Parker JD
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):645-50. PubMed ID: 10547079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal nitroglycerin in angina pectoris.
    Abrams J
    Eur Heart J; 1989 May; 10 Suppl A():11-9. PubMed ID: 2501090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroglycerin and long-acting nitrates in clinical practice.
    Abrams J
    Am J Med; 1983 Jun; 74(6B):85-94. PubMed ID: 6407316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial aldehyde dehydrogenase (ALDH-2)--maker of and marker for nitrate tolerance in response to nitroglycerin treatment.
    Daiber A; Wenzel P; Oelze M; Schuhmacher S; Jansen T; Münzel T
    Chem Biol Interact; 2009 Mar; 178(1-3):40-7. PubMed ID: 18834868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE).
    Kasanuki H; Hagiwara N; Hosoda S; Sumiyoshi T; Honda T; Haze K; Nagashima M; Yamaguchi J; Origasa H; Urashima M; Ogawa H;
    Eur Heart J; 2009 May; 30(10):1203-12. PubMed ID: 19346521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sublingual nitroglycerin in patients receiving transdermal nitroglycerin for coronary artery disease: prevention of cross-tolerance.
    Naito H; Matsuda Y; Yorozu T; Shiomi K; Maeda T; Seki K; Tada T; Fujii H
    Clin Cardiol; 1991 Aug; 14(8):644-50. PubMed ID: 1914267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dose-response relationship of nitrate therapy of angina pectoris].
    Schneider W; Kaltenbach M
    Z Kardiol; 1986; 75 Suppl 3():61-7. PubMed ID: 3099486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nitrate tolerance without reducing vascular response during eccentric dosing of nitrates.
    Morii H; Naito N; Nakano K; Kanamasa K
    Hypertens Res; 2006 Oct; 29(10):797-804. PubMed ID: 17283867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.